Market Cap

Hvsen Biotechnology Co. Ltd Market Capitalization:

CN¥4.30 Billion

CNY as of Jan. 1, 2026

US$612.9 Million

business Hvsen Biotechnology Co. Ltd Company Profile

Hvsen Biotechnology Co. Ltd Main Stock Listing

SZSE: 300871

Market Capitalization History of Hvsen Biotechnology Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Hvsen Biotechnology Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2026 CN¥4.30 B 105.53%
Jan. 1, 2025 CN¥2.09 B -11.25%
Jan. 1, 2024 CN¥2.36 B -31.85%
Jan. 1, 2023 CN¥3.46 B -13.90%
Jan. 1, 2022 CN¥4.02 B -15.62%
Jan. 1, 2021 CN¥4.76 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Hvsen Biotechnology Co. Ltd Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Hvsen Biotechnology Co. Ltd has the following listings and related stock indices.


Stock: SZSE: 300871

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.